Watch PBH. Know when insiders buy.
One email the day a filing lands. Free.
PBH
Prestige Consumer Healthcare Inc.
45.65
−0.27 −0.59%
USD · close Sep 24
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
33
FLAG · shorts 33
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.2BP/E 12.8DIV YIELD —FCF YIELD 10.88%REV TTM $1.1B −1.4%NET INCOME $172M −19.2%NET DEBT $904.8M52W 44.97 – 70.21SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | $265.7M | +6.5% | 51.3% | $52.5M | $29.2M | −38.5% | 0.61 | $70.8M | $3.7M | $67.1M | Aug 6 |
| Q4 2026 · Mar 31derived | $281.6M | −5.0% | 51.9% | $75.5M | $53.9M | +7.6% | 1.13 | $42.8M | $5.2M | $37.6M | May 14 |
| Q3 2026 · Dec 31 | $283.4M | −2.4% | 55.5% | $82.5M | $46.7M | −23.5% | 0.97 | $78.3M | $3M | $75.3M | Feb 5 |
| Q2 2026 · Sep 30 | $274.1M | −3.4% | 55.3% | $79.7M | $42.2M | −22.4% | 0.86 | $57.5M | $2.1M | $55.4M | Nov 6 |
| Q1 2026 · Jun 30 | $249.5M | −6.6% | 56.2% | $71.8M | $47.5M | −3.3% | 0.95 | $79M | $838K | $78.2M | Aug 6 |
| Q4 2025 · Mar 31derived | $296.5M | +7.0% | 57.3% | $88.4M | $50.1M | +1.4% | 1.01 | $61.8M | $3.5M | $58.4M | May 14 |
| Q3 2025 · Dec 31 | $290.3M | +2.7% | 55.5% | $92M | $61M | +15.1% | 1.22 | $65.1M | $1.6M | $63.5M | Feb 5 |
| Q2 2025 · Sep 30 | $283.8M | −0.9% | 55.5% | $84.3M | $54.4M | +1.5% | 1.09 | $69.8M | $2M | $67.8M | Nov 6 |
| Q1 2025 · Jun 30 | $267.1M | — | 54.7% | $72M | $49.1M | — | 0.98 | $54.8M | $1.2M | $53.6M | Aug 7 |
| Q4 2024 · Mar 31derived | $277M | — | 54.8% | $82.2M | $49.5M | — | 0.98 | $66.9M | $3.1M | $63.8M | May 14 |
| Q3 2024 · Dec 31 | $282.7M | — | 55.9% | $86.8M | $53M | — | 1.06 | $71.5M | $2M | $69.5M | Feb 6 |
| Q2 2024 · Sep 30 | $286.3M | — | 55.9% | $88.3M | $53.6M | — | 1.07 | $62.5M | $2.9M | $59.5M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | $1.1B | 54.7% | $309.4M | $190.3M | 17.5% | 3.91 | $257.6M | $11.2M | $246.4M | $156.3M | — |
| FY2025 · to Mar 31 | $1.1B | 55.8% | $336.8M | $214.6M | 18.9% | 4.29 | $251.5M | $8.2M | $243.3M | $51.5M | — |
| FY2024 · to Mar 31 | $1.1B | 55.5% | $342.4M | $209.3M | 18.6% | 4.17 | $248.9M | $9.6M | $239.4M | $25M | — |
| FY2023 · to Mar 31 | $1.1B | 55.4% | −$22.4M | −$82.3M | -7.3% | -1.65 | $229.7M | $7.8M | $221.9M | $50M | — |
| FY2022 · to Mar 31 | $1.1B | 57.1% | $329.9M | $205.4M | 18.9% | 4.04 | $259.9M | $9.6M | $250.3M | $0 | — |
| FY2021 · to Mar 31 | $943.4M | 58.0% | $297.4M | $164.7M | 17.5% | 3.25 | $235.6M | $22.2M | $213.4M | $11.9M | — |
Every number comes from Prestige Consumer Healthcare Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.